PerkinElmer’s laboratory kits enable both biomedical researchers and clinicians to learn what they need to know. That means the company’s products are in demand for multiple applications within its key target markets of laboratories and healthcare operators. The company is also well known in the community for its close collaboration with researchers and other areas of key centers of competence.
Moving forward, the company expects its immunodiagnostics to continue growing faster than the weighted average market growth rate, suggesting that its lead is becoming stronger. Likewise, management expects that its operating profit margin will continue to expand over the next few years, paving the way for faster earnings growth. In the long term, PerkinElmer might even diversify its line of business to increase its revenue.